Media

For Media Inquires contact: 

1 (862) 261-8030 

Not a member of the Media?

View our full contact list 

Acquisition of Allergan plc by AbbVie Inc.

Latest News Releases

View All News Releases

Allergan Declares Second Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share

AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction

Announcement under the Irish Takeover Rules: Relevant Securities in Issue - March 10, 2020

Allergan Receives FDA Approval for DURYSTA™ (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients

Announcement under the Irish Takeover Rules: Relevant Securities in Issue - March 3, 2020

Latest Documents

Media Resources

General Information

Latest Articles

View All Articles
vault opening

Celebrating Our History + Bold Future
allergan colleagues make donation to china red cross

Allergan Donates ¥1 Million to Aid China in the Fight Against Coronavirus

the allergan foundation

The Allergan Foundation Gives Back
globe-australia

Allergan Aids Australia Wildfire Relief
abstract pink design

$200,000 Awarded in Funding for the Tissue Innovation Challenge

Allergan 360° Aesthetics Report™ Reveals Evolving Beauty Perceptions and Diverse Priorities Around the World

CEO Blog

View All Blogs
Doctor on laptop with social media icons surrounding her

Social Media Enhances My Interactions with Customers